The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2022

Filed:

Jul. 09, 2014
Applicants:

University of North Texas Health Science Center AT Fort Worth, Fort Worth, TX (US);

Board of Regents, the University of Texas System, Austin, TX (US);

Inventors:

Sid E. O'Bryant, Aledo, TX (US);

Robert C. Barber, Benbrook, TX (US);

Guanghua Xiao, Coppell, TX (US);

Dwight German, Dallas, TX (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); G16B 25/00 (2019.01); G16B 20/20 (2019.01); G16B 25/10 (2019.01); A61B 5/00 (2006.01); G16B 20/00 (2019.01); G16B 20/40 (2019.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); A61B 5/4088 (2013.01); G16B 20/00 (2019.02); G16B 20/20 (2019.02); G16B 20/40 (2019.02); G16B 25/00 (2019.02); G16B 25/10 (2019.02); G01N 2570/00 (2013.01); G01N 2800/28 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/2835 (2013.01); G01N 2800/387 (2013.01);
Abstract

The present invention includes methods and kits for the diagnosing a neurological disease within primary care settings comprising: obtaining a blood test sample from a subject, measuring IL-7 and TNFα biomarkers in the blood sample, comparing the level of the one or a combination of biomarkers and neurocognitive screening tests with the level of a corresponding one or combination of biomarkers in a normal blood sample and neurocognitive screening tests, and predicting that an increase in the level of the blood test sample in relation to that of the normal blood sample indicates that the subject is likely to have a neurological disease.


Find Patent Forward Citations

Loading…